腫瘍遺伝子およびポリコンブ群遺伝子bmi-1は,ink4aロカスを通して細胞増殖と衰老を調節する
J J Jacobs1, K Kieboom, S Marino
1Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam.
Nature
|January 29, 1999
まとめ
ポリコンブ群のタンパク質であるbmi-1遺伝子は,細胞サイクル進行と衰老を調節する. 欠乏すると欠陥が生じ,過剰発現するとリンパ腫や癌が生じ,腫瘍抑制における役割を強調する.
科学分野:
- 分子生物学は分子生物学である.
- 発達生物学 発達生物学とは
- がん研究 がん研究
背景:
- Bmi-1はポリコンブ群のタンパク質で,発達中の遺伝子静止に関与しています.
- Bmi-1の調節不良は,がんや発達異常と関連しています.
- ポリコンブ群のタンパク質は,発達に不可欠な安定した遺伝子抑制を維持します.
研究 の 目的:
- 細胞サイクル制御と衰老におけるbmi-1の役割を調査する.
- Bmi-1.のインビボ標的を特定する.
- ポリコンブ群のタンパク質,細胞サイクル調節,老化との関連を解明する.
主な方法:
- bmi-1-欠乏したマウスの胚性線維芽細胞とリンパ球の分析.
- 細胞サイクル進行と老化マーカーの評価.
- 腫瘍抑制剤p16とp19Arfの遺伝子発現分析 (ink4aでコードされている).
- ファイブロブラストの不死化と変容に対するbmi-1過剰発現の影響の評価.
主要な成果:
- bmi-1欠乏は細胞サイクル進行を阻害し,線維芽細胞の早期老化を誘発する.
- bmi-1欠乏症は,腫瘍抑制剤p16およびp19Arf.の発現の増加につながります.
- bmi-1過剰発現は,線維芽細胞の不死化と腫瘍変異を促進する.
- インク4aの除去は,bmi-1-欠乏したマウスのリンパ性および神経学的欠陥を救います.
結論:
- Bmi-1は,ポリコンブ群のタンパク質を細胞サイクル制御と衰老に結びつける転写抑制剤として作用する.
- Ink4aは,Bmi-1によって調節される重要なインビボ標的遺伝子です.
- Bmi-1は,早老化を予防し,正常な発達を維持する上で重要な役割を果たします.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...


